-
-
-
-
-
-
-
Pacira BioSciences Mails Letter to Stockholders Reiterating Confidence in the Company’s Strategic Direction and Highly Qualified Nominees
-
-
-
-
-
-
-
DOMA Perpetual launches proxy fight for three Pacira BioSciences board seats
-
-
-
-
-
-
-
Pacira BioSciences Files Definitive Proxy Materials and Mails Letter to Shareholders
-
-
-
-
-
-
-
DOMA Perpetual nominates three directors for Pacira BioSciences board
-
-
-
-
-
-
-
Pacira Announces Agreement with LG Chem to Make EXPAREL® Available in Select Asian-Pacific Markets
-
-
-
-
-
-
-
Pacira BioSciences licenses pain drug from AmacaThera for $5M upfront
-
-
-
-
-
-
-
Pacira BioSciences Reports Second Quarter 2025 Financial Results
-
1,206,889 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

